Regulatory11 Aug 2026, 05:11 pm
JHS Svendgaard: No Deviation in Preferential Issue Fund Utilization for Q2 2026
AI Summary
JHS Svendgaard Laboratories Ltd has filed its Statement of Deviation and Variation for the quarter ended June 30, 2026, concerning funds raised via Preferential Issue. The company reported no deviation or variation in the utilization of funds. The funds were raised on June 4, 2024, amounting to ₹29.99 crores. The utilization details for setting up a new project in Jammu & Kashmir, general corporate purposes, and infusion of funds into a group entity (JHS Svendgaard Retail Ventures Ltd.) show that the utilized amounts align with the original allocations, with no discrepancies noted for the reported quarter. The information is available on the company's website.
Key Highlights
- No deviation reported in preferential issue fund utilization for Q2 2026.
- Funds raised were ₹29.99 crores on June 4, 2024.
- Utilization aligned with original objects for project, corporate, and subsidiary funding.
- Statement filed as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Information available on the company's official website.
Price Impact
More from JHS